NYSE: AAgilent Technologies Inc Stock
$123.28-0.89 (-0.72%)
Updated Jul 11, 2025
A Price
$123.28
Fair Value Price
N/A
Market Cap
$35.02B
52 Week Low
$96.43
52 Week High
$153.84
P/E
30.29x
P/B
5.71x
P/S
4.63x
PEG
1.5x
Dividend Yield
0.39%
Revenue
$6.63B
Earnings
$1.17B
Gross Margin
53.3%
Operating Margin
22.36%
Profit Margin
17.6%
Debt to Equity
0.98
Operating Cash Flow
$2B
Beta
1.02
Next Earnings
Aug 19, 2025
Ex-Dividend
Jul 1, 2025
Next Dividend
Jul 23, 2025
A Overview
Agilent Technologies, Inc. manufactures analytical instruments for the food, environmental and forensics, pharmaceutical, diagnostics, chemical and energy, and research sector. Agilent was spun off from Hewlett-Packard in 1999. Until 2014, the company also produced test and measurement equipment for the electronics industry. That division was spun off to form Keysight. Agilent is headquartered in Santa Clara, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine A's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important A news, forecast changes, insider trades & much more!
A News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how A scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
A ($123.28) is trading above its intrinsic value of $51.57, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
A is good value based on its earnings relative to its share price (30.29x), compared to the US market average (30.99x)
P/E vs Market Valuation
A is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more A due diligence checks available for Premium users.
Valuation
A price to earnings (PE)
For valuing profitable companies with steady earnings
Company
30.29x
Industry
20.92x
Market
30.99x
A is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
A is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
A price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
5.71x
Industry
3.66x
A is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
A price to earnings growth (PEG)
For valuing profitable companies with growth potential
A is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
A's financial health
Profit margin
Revenue
$1.7B
Net Income
$215.0M
Profit Margin
12.9%
A's Earnings (EBIT) of $1.48B... subscribe to Premium to read more.
Interest Coverage Financials
A's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$12.2B
Liabilities
$6.0B
Debt to equity
0.98
A's short-term assets ($4.21B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
A's short-term assets ($4.21B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
A's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
A's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$221.0M
Investing
-$114.0M
Financing
-$116.0M
A's operating cash flow ($1.59B)... subscribe to Premium to read more.
Debt Coverage Financials
A vs Diagnostic & Research Stocks
Agilent Technologies Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.